SOCS1,LCP1,CD79A,PRF1,CD74,B2M,HLA-A,TNFRSF14,CDKN1A,ID3,LMO2,LEF1,AXIN2,CREB3L1,TENT5C,ALDH2,CDH1,TMPRSS2,ESR1,PIK3R1,TP53,GATA2,FGFR2,MECOM,ERBB4,PREX2,MET,POU5F1,PAX8,FGFR4,TFRC,CDKN2C,CDKN1B,CCNE1,APOBEC3B,CXCR4,MYCL,NFIB,CEBPA,NDRG1,MYC,BCL9L,WT1,BCL6,SLC34A2,MUC16,IGF2BP2,HMGA1,TPM4,CDKN2A,MLF1,SDHD,BTG2,JUN,KLF6,SGK1,BIRC3,TNFAIP3,PTK6,CBLC,MUC1,ELF3,BCL3,CARD11,ERBB3,MACC1,TBX3,FAT1,PTPN13,TNC,PRRX1,MLLT11,CHST11,SFRP4,HOXA11,FSTL3,CSF1R,SIRPA,PDGFRA,MAF,MAFB,PDGFRB,COL3A1,COL1A1,CDH11,CCND1,ETV4,ETV5,SIX1,FGFR1,MYCN,CCND2,ERBB2,ATP1A1,PCBP1,WNK2,FBLN2,ELN,FGFR3,ACKR3,age_at_index,days_to_birth,year_of_birth,age_at_diagnosis,days_to_last_follow_up,year_of_diagnosis,treatment_or_therapy_yes,treatment_or_therapy_no,race_american indian or alaska native,race_asian,race_black or african american,race_native hawaiian or other pacific islander,race_not reported,race_white,figo_stage_Stage I,figo_stage_Stage IA,figo_stage_Stage IB,figo_stage_Stage IC,figo_stage_Stage II,figo_stage_Stage IIA,figo_stage_Stage IIB,figo_stage_Stage IIC,figo_stage_Stage III,figo_stage_Stage IIIA,figo_stage_Stage IIIB,figo_stage_Stage IIIC,figo_stage_Stage IIIC1,figo_stage_Stage IIIC2,figo_stage_Stage IV,figo_stage_Stage IVA,figo_stage_Stage IVB,morphology_8020/3,morphology_8140/3,morphology_8310/3,morphology_8380/3,morphology_8382/3,morphology_8440/3,morphology_8441/3,morphology_8460/3,morphology_8461/3,morphology_8720/3,morphology_8890/3,morphology_8896/3,morphology_8980/3,morphology_9680/3,"primary_diagnosis_Adenocarcinoma, NOS","primary_diagnosis_Carcinoma, undifferentiated, NOS","primary_diagnosis_Carcinosarcoma, NOS","primary_diagnosis_Clear cell adenocarcinoma, NOS","primary_diagnosis_Cystadenocarcinoma, NOS","primary_diagnosis_Diffuse large B-cell lymphoma, NOS","primary_diagnosis_Endometrioid adenocarcinoma, NOS","primary_diagnosis_Endometrioid adenocarcinoma, secretory variant","primary_diagnosis_Leiomyosarcoma, NOS","primary_diagnosis_Malignant melanoma, NOS",primary_diagnosis_Myxoid leiomyosarcoma,primary_diagnosis_Papillary serous cystadenocarcinoma,"primary_diagnosis_Serous cystadenocarcinoma, NOS",primary_diagnosis_Serous surface papillary carcinoma,prior_malignancy_no,prior_malignancy_not reported,prior_malignancy_yes,site_of_resection_or_biopsy_Corpus uteri,site_of_resection_or_biopsy_Endometrium,site_of_resection_or_biopsy_Fundus uteri,site_of_resection_or_biopsy_Ovary,"site_of_resection_or_biopsy_Uterus, NOS","site_of_resection_or_biopsy_Vagina, NOS","site_of_resection_or_biopsy_Vulva, NOS",synchronous_malignancy_No,synchronous_malignancy_Not Reported,synchronous_malignancy_Yes,tissue_or_organ_of_origin_Corpus uteri,tissue_or_organ_of_origin_Endometrium,tissue_or_organ_of_origin_Fundus uteri,"tissue_or_organ_of_origin_Hematopoietic system, NOS",tissue_or_organ_of_origin_Ovary,"tissue_or_organ_of_origin_Skin, NOS","tissue_or_organ_of_origin_Uterus, NOS","treatment_type_Pharmaceutical Therapy, NOS","treatment_type_Pharmaceutical Therapy, NOS, Chemotherapy, Radiation Therapy, NOS","treatment_type_Pharmaceutical Therapy, NOS, Radiation Therapy, NOS","treatment_type_Radiation Therapy, NOS","treatment_type_Surgery, NOS, Immunotherapy (Including Vaccines), Brachytherapy, High Dose, Hormone Therapy, Chemotherapy, Targeted Molecular Therapy","treatment_type_Surgery, NOS, Immunotherapy (Including Vaccines), External Beam Radiation, Hormone Therapy, Chemotherapy, Targeted Molecular Therapy","treatment_type_Surgery, NOS, Immunotherapy (Including Vaccines), Hormone Therapy, Brachytherapy, High Dose, Chemotherapy, Targeted Molecular Therapy","treatment_type_Surgery, NOS, Immunotherapy (Including Vaccines), Hormone Therapy, Chemotherapy, Radiation, Intensity-Modulated Radiotherapy, Targeted Molecular Therapy",ethnicity_hispanic or latino,ethnicity_not hispanic or latino,ethnicity_not reported
